AMA responds to administration blueprint to tackle rising drug prices

| 1 Min Read

CHICAGO — The American Medical Association (AMA) sent the following letter in response to the Trump Administration’s request for comments to its plan to lower drug prices. The letter from AMA CEO and Executive Vice President James L. Madara, M.D., was sent to Health and Human Services Secretary Alex M. Azar II.

 

 

 

Full press release available when you sign in

Sign in to the AMA website to get the full version of this press release. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Man power walking or jogging, with dumbbells

New changes expand diabetes-prevention for more Medicare patients

| 3 Min Read
Three healthcare workers in discussion

AMA Joy in Medicine points the way to better care

| 5 Min Read
Doctors hold up magnifying glasses over a giant pancreas

Beyond watch and wait: Taking aim at pancreatic cysts

| 7 Min Read
Philip Kuriakose, MD, featured on "Health vs. Hype" AMA podcast

5 things patients should know about microplastics

| 8 Min Read